Getein Biotech, Inc (SHA:603387)

Getein Biotech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	1,165	1,355	1,816	1,398	1,120
Other Revenue	-	14.45	6.18	3.62	3.73
Revenue	1,165	1,369	1,822	1,402	1,123
Revenue Growth (YoY)	-14.93%	-24.85%	29.98%	24.78%	16.02%
Cost of Revenue	358.42	465.31	671.56	485.42	414.42
Gross Profit	806.37	903.85	1,150	916.29	708.92
Selling, General & Admin	371.6	454.27	407.26	324.08	258.6
Research & Development	181.21	217.99	223.22	163.39	119.07
Other Operating Expenses	-22.06	0.14	-0.07	12.55	11.27
Operating Expenses	544.45	691.61	653.29	506.69	401.43
Operating Income	261.93	212.24	497.01	409.59	307.49
Interest Expense	-14.93	-16.94	-16.61	-14.31	-6.22
Interest & Investment Income	45.79	72.02	45.5	47.97	35.49
Currency Exchange Gain (Loss)	-	11.31	19.41	-0.97	-9.64
Other Non Operating Income (Expenses)	0.69	-0.54	-3.29	-4.42	-6.49
EBT Excluding Unusual Items	293.48	278.09	542.03	437.86	320.63
Gain (Loss) on Sale of Investments	0.15	10.25	18.46	-4.29	24.41
Gain (Loss) on Sale of Assets	1.59	0.67	0.02	0.95	0.57
Asset Writedown	-41.79	-1.69	-0.53	-	-
Other Unusual Items	-	17.63	-	17.11	28.43
Pretax Income	253.43	304.94	559.98	451.63	374.04
Income Tax Expense	23.55	20.86	56.03	39.62	43.73
Earnings From Continuing Operations	229.88	284.08	503.94	412.01	330.31
Minority Interest in Earnings	-6.24	-4.31	-5.03	-13.02	-25.58
Net Income	223.64	279.77	498.91	398.99	304.73
Net Income to Common	223.64	279.77	498.91	398.99	304.73
Net Income Growth	-20.06%	-43.92%	25.04%	30.93%	-10.29%
Shares Outstanding (Basic)	508	509	509	505	508
Shares Outstanding (Diluted)	508	509	509	512	508
Shares Change (YoY)	-0.08%	-0.08%	-0.48%	0.72%	-0.82%
EPS (Basic)	0.44	0.55	0.98	0.79	0.60
EPS (Diluted)	0.44	0.55	0.98	0.78	0.60
EPS Growth	-20.00%	-43.88%	25.64%	30.00%	-9.54%
Free Cash Flow	266.6	75.09	265.51	252.77	71.94
Free Cash Flow Per Share	0.53	0.15	0.52	0.49	0.14
Dividend Per Share	-	0.200	0.340	0.243	0.184
Dividend Growth	-	-41.18%	39.98%	32.30%	-10.04%
Gross Margin	69.23%	66.02%	63.14%	65.37%	63.11%
Operating Margin	22.49%	15.50%	27.28%	29.22%	27.37%
Profit Margin	19.20%	20.43%	27.38%	28.46%	27.13%
Free Cash Flow Margin	22.89%	5.49%	14.57%	18.03%	6.40%
EBITDA	349.16	296.38	561.95	457.04	343.42
EBITDA Margin	29.98%	21.65%	30.84%	32.61%	30.57%
D&A For EBITDA	87.23	84.14	64.93	47.44	35.93
EBIT	261.93	212.24	497.01	409.59	307.49
EBIT Margin	22.49%	15.50%	27.28%	29.22%	27.37%
Effective Tax Rate	9.29%	6.84%	10.01%	8.77%	11.69%
Revenue as Reported	1,165	1,369	1,822	1,402	1,123
Advertising Expenses	-	43.56	47.32	36.19	38.44

Updated Oct 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.